Nepafenac and dexamethasone nanomicelles laden in situ gel for treating post cataract inflammation, has drug loaded nanomicelles, thermosensitive polymer and mucoadhesive polymer, where drug loaded nanomicelles comprise nepafenac, dexamethasone, thermosensitive polymer, surfactant or organic solvent
	MANSI P; GANDHI T R; RANA H B; THAKKAR V T; SMIT M S
	2023-08-14
专利权人	ANAND PHARMACY COLLEGE (ANAN-Non-standard)
申请日期	2023-08-14
专利号	IN202321054553-A
成果简介	NOVELTY - Nepafenac and dexamethasone nanomicelles laden in situ gel comprises drug loaded nanomicelles, thermosensitive polymer and mucoadhesive polymer, where the drug loaded nanomicelles comprises nepafenac, dexamethasone, thermosensitive polymer, surfactant, and organic solvent. USE - Nepafenac and dexamethasone nanomicelles laden in situ gel for treatment of post cataract inflammation. No biological data is given. ADVANTAGE - The gel has controlled release of drug and increase the residence time; avoids drug leaching, nasolacrimal drainage, tear reflux and excessive blinking; improves patient compliance; and improves solubility and permeability of the drug lead to improve bioavailability.
IPC 分类号	A61K-031/573 ; A61K-047/69 ; A61K-009/08 ; A61K-009/51 ; A61P-029/00
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/20817
专题	中国科学院新疆生态与地理研究所
作者单位	ANAND PHARMACY COLLEGE (ANAN-Non-standard)
推荐引用方式 GB/T 7714	MANSI P,GANDHI T R,RANA H B,et al. Nepafenac and dexamethasone nanomicelles laden in situ gel for treating post cataract inflammation, has drug loaded nanomicelles, thermosensitive polymer and mucoadhesive polymer, where drug loaded nanomicelles comprise nepafenac, dexamethasone, thermosensitive polymer, surfactant or organic solvent. IN202321054553-A[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。